GLAS · Glass House Brands Inc.

Track GLAS — free

$4.40 -0.01 (-0.18%)

Rebalance outlook locked

Market Cap

$415.61M

94.24M

Volume · Oct 8 4.9M Avg daily vol (3M) 801.04K

Up next

Next earnings call

Oct 23, 2026 Est · unconfirmed · in 2 wks

Q2 2026 earnings call transcript

call held Aug 13, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

View all 115 metrics

Revenue (TTM)

—

Trailing 12 months

Net income (TTM)

—

Trailing 12 months

Revenue growth YoY

—

Year over year

Operating margin

—

Trailing 12 months

P / E (TTM)

—

Trailing earnings

FCF yield

—

TTM · current market cap

Return on invested capital

—

Trailing 12 months

Net cash

—

Latest balance sheet

Dividend yield

—

Trailing 12 months

Shares change YoY

—

Year over year · more shares

Price change (1Y)

-36.7%

Trailing year

Short interest

0.2%

Latest settlement · 1.0 days to cover

View all 115 metrics

Equibles Rating

blended score · not investment advice

Overall

Strong Sell

SellHoldBuy

Technical Strong Sell Momentum Very Weak Sentiment Neutral Fundamentals Poor Quant / Vol Very High

Market backdrop VIX 15.4 · calm Equity put/call 0.62

Technical

price trend

Strong Sell

50 / 200-day cross No cross

Price vs 200-day avg −53%

below

Price vs 50-day avg −48%

below

RSI (14) 14

oversold

MACD trend Negative

52-week position 0%

near low

Volume (OBV) Confirms

volume backs price

Momentum

relative strength

Very Weak

1-month return −45%

trailing

6-month return −47%

trailing

YTD return −50%

this year

Relative strength −56%

vs S&P · 6-mo

Sentiment

smart money

Neutral

Trend (MA cross) No cross

50d $8 › 200d $9 — 200d above 50d

Institutional flow Accumulating

1 of 53 funds reported for Sep 30 · net +5.3K sh shares · +1 new

Insider flow Distributing

Net -$30.7K over 90 days · 100% sells

Short interest Rising

0.21% of float · ▲ +8.6% MoM · 1.0 days cover

Volume signal Reversal watch

High volume on a down day — possible exhaustion

Institution breadth Multi-yr high

53 holders — near 3-yr high, broad support

Squeeze score 28

low risk · 0–100

Fundamentals

Poor

Revenue growth −9%

Y/Y

Gross margin 42%

contracting

EPS growth −162%

Y/Y

Free cash flow $-15.7M

Balance sheet $45.3M

net debt

Quant / Vol

risk profile

Very High

Volatility 94%

annualized · 1-yr

Max drawdown −68%

past year

ATR 12.1%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Strong Sell

4 · 3 · 0

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

−53% Bearish

Price vs 50-day avg

−48% Bearish

RSI (14)

14 Neutral

MACD trend

Negative Bearish

52-week position

0% Bearish

Volume (OBV)

Confirms Neutral

Market signals — smart money & positioning

Mixed

Trend (MA cross) No cross

50d $8 › 200d $9 — 200d above 50d

Institutional flow Accumulating

1 of 53 funds reported for Sep 30 · net +5.3K sh shares · +1 new

Insider flow Distributing

Net -$30.7K over 90 days · 100% sells

Short interest Rising

0.21% of float · ▲ +8.6% MoM · 1.0 days cover

Volume signal Reversal watch

High volume on a down day — possible exhaustion

Institution breadth Multi-yr high

53 holders — near 3-yr high, broad support

Price context

position in its 52-week range

Range low $4 Now $4 · 0% Range high $14

vs 200-day avg -53% vs 50-day avg -48%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Drug Manufacturers - Specialty & Generic — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
GLAS Glass House Brands Inc. this stock	$415.61M	-50.2%	-9.4%	—	0.2%
TAK Takeda Pharmaceutical Co Ltd	$59.16B	+18.8%	—	—	0.1%
GALDY Galderma Group AG/ADR	$45.83B	-5.0%	—	—	0.0%
TEVA Teva Pharmaceutical Industries Ltd	$45.74B	+25.8%	+4.3%	64.3	2.7%
JHPCY Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR	$41.48B	—	—	—	0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Accumulating

Holders

% held: 19.7%
Reported: 1 of 53
Top holder: Park West Asset Managemen…

Held Float

View

Held by Funds

Fund positions

View

Short & Settlement

Short Interest Rising

Shares short

199.8K

Days to cover: 1.0d
Change: +15.8K sh

View

Short Volume

Short vol %

20%

As of: Oct 8, 2026

Short Total

View

Fails to Deliver

FTD shares

35.9K

Value: $284.5K
As of: Sep 14, 2026

View

Off-Exchange

Off-exchange %

55.5%

Week of: Aug 31, 2026

Off-exch Lit

View

Smart Money

Insider Trades Net selling

Net (90d)

-$30.7K

Buyers / Sellers: 0 / 1

Buyers Sellers

View

Congressional Trades Buy

Member

Max Miller

Amount: $1.0K–$15.0K
Traded: Sep 10, 2024

View

Financials

Revenue (FY)

$182.0M

Net income (FY): $-29.7M
EPS diluted: $-0.55

View

Filings

SEC Filings

Latest

6-K

Filed: Sep 29, 2026
This year: 12

View

Proposed Sales

Value

$416.0K

Shares: 40.0K
Filed: Aug 28, 2026

View

Exempt Offerings

Offering

$5.0M

Filed: Jan 12, 2023

View

Earnings & Events

Webcasts

Last webcast

Aug 13, 2026

View

Performance

	5D	20D	120D	MTD	YTD
GLAS	-17.1%	-44.7%	-46.9%	-21.4%	-50.2%
SPY	+1.3%	+2.1%	+9.0%	+1.5%	+13.5%
vs SPY	-18.4%	-46.9%	-55.9%	-22.9%	-63.7%

Key facts CIK 1848731 CUSIP 377130406 13F (30d) 1 filings 1 filers Visit website Investor relations

GLAS · Glass House Brands Inc.

Price & Indicators

Up next

Metrics snapshot

Equibles Rating

Technicals

Versus peers

At a glance

Performance